We collected information about Delcath Systems Inc Hours for you. Follow the liks to find out everything about Delcath Systems Inc Hours.
https://www.nasdaq.com/market-activity/stocks/dcth/after-hours
Delcath Systems, Inc. Common Stock (DCTH) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.
https://www.marketwatch.com/investing/stock/dcth
Delcath Systems, Inc. (DCTH) Reports Q1 Loss, Tops Revenue Estimates May. 11, 2021 at 9:20 a.m. ET on Zacks.com Delcath Systems (DCTH) Received its Third Buy in a Row
https://newsheater.com/2021/12/02/is-there-a-dimmer-outlook-ahead-for-delcath-systems-inc-dcth/
Delcath Systems Inc. (NASDAQ:DCTH) went down by -8.34% from its latest closing price compared to the recent 1-year high of $25.18. The company’s stock price has collected 5.54% of gains in the last five trading sessions. Press Release reported 2 hours ago that Delcath Systems, Inc. Announces Positive Phase 3 FOCUS Trial Results for Hepzato(TM) in Liver-Dominant Metastatic Ocular Melanoma ...
https://finance.yahoo.com/quote/DCTH
NEW YORK, Oct. 25, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver ...
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=132392963
Delcath Systems EPS beats by $0.14, beats on revenue Seeking Alpha - 11/9/2021 7:33:04 AM: Delcath Systems Announces Third Quarter 2021 Results GlobeNewswire Inc. - 11/9/2021 7:30:00 AM: Delcath Systems Q3 2021 Earnings Preview Seeking Alpha - 11/8/2021 1:40:51 PM
https://www.marketwatch.com/investing/stock/dcth/company-profile
Delcath Systems Inc. Delcath Systems, Inc. is an oncology company, which focuses on the treatment of primary and metastatic liver cancers. It develops and commercializes CHEMOSAT and Melphalan ...
https://www.nasdaq.com/articles/delcath-systems-inc.-dcth-reports-q3-loss-misses-revenue-estimates
Delcath Systems, Inc. (DCTH) came out with a quarterly loss of $0.94 per share versus the Zacks Consensus Estimate of a loss of $0.91. This compares to loss of $1.16 per share a …
https://www.barrons.com/market-data/stocks/dcth/research-ratings
Delcath Systems Inc. Delcath Systems, Inc. is an oncology company, which focuses on the treatment of primary and metastatic liver cancers. It …
Searching for Delcath Systems Inc Hours?
You can just click the links above. The info is collected for you.
